Drug intelligence / Profile preview

SB cell

Development stage: Phase 1
Modality: Stem Cell Therapies → Cell Therapies
Administration: Local (applied At Surgical/implant Site)

Overview

SB cell refers to a cellular therapy product investigated for its potential to enhance osseointegration in guided bone regeneration during implant surgery. The therapy involves the use of specific cells (the exact type is not specified in available sources) intended to improve the integration of implants with bone tissue, potentially leading to better outcomes in dental or orthopedic implant procedures. The primary mechanism is likely related to promoting bone regeneration and healing at the site of implantation, but detailed mechanistic information is not provided in public records[1].

Other names: SB cells

Beyond the preview

Go deeper on SB cell.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SB cell.

Explore the full profile